Pharmacist Pain Management Podcast 30 credit minutes

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

Learning Objectives

Upon successful completion of this course, learners should be able to:
1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing. 
2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Michelle Moser, RPh

Retired Compounding Pharmacist

Disclosures:

Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.

Course Details